Invention Grant
- Patent Title: Mucin antigen vaccine
-
Application No.: US14256091Application Date: 2014-04-18
-
Publication No.: US09402920B2Publication Date: 2016-08-02
- Inventor: Yucheng Tang , Albert Deisseroth
- Applicant: MicroVAX, LLC
- Applicant Address: US VA Warrenton
- Assignee: MicroVAX, LLC
- Current Assignee: MicroVAX, LLC
- Current Assignee Address: US VA Warrenton
- Agent Jacob Frank; Glenn Snyder
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K39/00 ; C07K14/47 ; C07K14/705 ; C12N15/85 ; A61K9/127

Abstract:
Provided are expression vectors for generating an immune response to a mucin. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal, a mucin antigen and CD40 ligand. Also provided are methods of generating an immune response against cells expressing a mucin by administering an effective amount of the vector. Further provided are methods of generating an immune response against cancer cells expressing a mucin in an individual by administering an effective amount of the vector. Still further provided are methods of overcoming anergy to a mucin self antigen by administering an effective amount of the vector.
Public/Granted literature
- US20140322301A1 MUCIN ANTIGEN VACCINE Public/Granted day:2014-10-30
Information query